Skip to content

GeneDx Holdings

US · WGS #2702 by market cap Listed 1970
45.46 -3.78 -7.68%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About GeneDx Holdings

GeneDx Holdings Corp. is a rare disease diagnosis company, with a mission to empower everyone to live their healthiest life through genomics. The firm combines clinical expertise, advanced technology, and the power of GeneDx Infinity. This foundation powers GeneDx's ExomeDx and GenomeDx tests, enabling clinicians to deliver precise, fast, and actionable diagnoses. The Infinity also fuels discovery for biopharma with AI-driven genomic intelligence. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Founded
2020
CEO
Ms. Katherine A. Stueland
Employees
1,300
Headquarters
Stamford, Connecticut, United States of America
Fiscal year end
12-31
Website
genedx.com

Company profile

Exchange
US
Symbol
WGS
Market-cap rank
#2702
Listing date
1970-01-01
Market cap
1.36B
Float cap
854.34M
Shares out
29.97M
Float shares
18.79M

Sectors & themes

Diagnostics & Research Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

GeneDx Holdings discussion 0 comments

Add a comment